These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9930969)

  • 1. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
    Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
    J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
    Kuttler B; Kauert C; Wanka H; Diamantstein T; Hahn HJ
    J Autoimmun; 1996 Jun; 9(3):321-9. PubMed ID: 8816967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats.
    Kuttler B; Rösing K; Hahn HJ
    Transplant Proc; 1997 Jun; 29(4):2163-5. PubMed ID: 9193572
    [No Abstract]   [Full Text] [Related]  

  • 5. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and suppression of autoimmune pancreatic beta-cell destruction in BB rats by syngeneic lymphocytes obtained from long-term normoglycaemic donors.
    Kuttler B; Dunger A; Volk HD; Diamantstein T; Hahn HJ
    Diabetologia; 1991 Feb; 34(2):74-7. PubMed ID: 2065851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
    Kuttler B; Mathieu C; Bulfone-Paus S; Bouillon R; Diamantstein T; Hahn HJ
    Transplant Proc; 1998 Dec; 30(8):4140-2. PubMed ID: 9865327
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
    Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
    Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
    [No Abstract]   [Full Text] [Related]  

  • 12. Syngeneic islet transplantation in prediabetic BB-DP rats--a synchronized model for studying beta-cell destruction during the development of IDDM.
    Christensen UB; Sparre T; Cooke A; Andersen HU; Mandrup-Poulsen T; Nerup J
    Autoimmunity; 1998; 28(2):91-107. PubMed ID: 9771979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of recurrence of insulin-dependent diabetes mellitus in syngeneic and allogeneic islet-transplanted diabetic biobreeding rats.
    Kaino Y; Ito T; Goto Y; Hirai H; Kida K
    Transplantation; 1998 Jun; 65(12):1543-8. PubMed ID: 9665068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat.
    Uchikoshi F; Yang ZD; Rostami S; Yokoi Y; Capocci P; Barker CF; Naji A
    Diabetes; 1999 Mar; 48(3):652-7. PubMed ID: 10078573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy.
    Wang T; Singh B; Warnock GL; Rajotte RV
    Diabetes; 1992 Jan; 41(1):114-7. PubMed ID: 1727730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
    Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
    Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.
    Arefanian H; Tredget EB; Rajotte RV; Korbutt GS; Gill RG; Rayat GR
    Cell Transplant; 2007; 16(8):787-98. PubMed ID: 18087999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD mice have a generalized defect in their response to transplantation tolerance induction.
    Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
    Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats.
    Kuttler B; Wanka H; Klöting N; Gerstmayer B; Volk HD; Sawitzki B; Ritter T
    J Cell Mol Med; 2007; 11(4):868-80. PubMed ID: 17760846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.